Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer. Cancer. 2007 Feb 15;109(4):732-40.

Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience. Lung Cancer. 2006 Apr;52(1):75-81

Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer. Med Oncol. 2005;22(4):359-66.

A phase II study of weekly paclitaxel, cisplatin and concurrent radiation therapy for locally-advanced unresectable non-small cell lung cancer: early closure due to lack of efficacy. Cancer Reaseach and Treatment 2004;36:293-297

A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Advanced Non-small-cell Lung Cancer. Cancer Reaseach and Treatment 2003, 35(3)239-244

Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res. 2002 May-Jun;30(3):220-9

국한성 소세포 폐암에 대한 Etoposide (VP-16), Ifosfamide, Carboplatin 복합화학요법과 흉부 방사선의 동시 병합치료 효과. (A phase II study of etoposide (VP-16), ifosfamide, and carboplatin combination chemotherapy plus concurrent thoracic irradiation for limited stage small cell lung cancer.) The Korean Journal of Medicine 2006 ; 70 (4) : p.402~409

확장기 소세포 폐암에서 Carboplatin, Ifosfamide, Etoposide 복합화학요법의 효과 (Carboplatin, ifosfamide, and etoposide chemotherapy for extensive-disease small cell lung cancer). The Korean Journal of Medicine 2006 ; 70 (6) : p.688~694

A Multicenter, phase III Clinical trial of Leucogreen® (G-CSF) for chemotherapy-induced neutropenia in solid tumors. Kor J Clin Pharmacol Ther, 11(1); 38-47, 2003

진행성 비소세포폐암 환자에서 Vinorelbine, Ifosfamide 복합화학요법 (Combination chemotherapy with vinorelbine and ifosfamide for advanced non-small cell lung cancer). The Korean Journal of Medicine 2001:60:1 70 - 77